Information
-
Trademark
-
98697887
-
International Classifications
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
- 5 - Pharmaceutical and veterinary preparations
- 7 - Machines and machine tools
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
- 42 - Scientific and technological services and research and design relating thereto
- 44 - Medical services
-
Filing Date
August 14, 2024
a year ago
-
Transaction Date
July 15, 2025
4 months ago
-
Status Date
July 14, 2025
4 months ago
-
Location Date
June 03, 2025
5 months ago
-
Status Code
680
-
Current Location
TMO LAW OFFICE 127
Employee Name
SCHRADER, BRITTANY
-
Attorney Docket Number
067249-00064
Attorney Name
Jennifer Fraser
Law Office Assigned Location Code
N90
-
Owners
Mark Drawing Code
4
Mark Identification
SHAREVAC
Case File Statements
- GS0091: Scientific and laboratory apparatus for chemical synthesis; laboratory equipment, namely, mobile laboratory equipped with scientific or laboratory apparatus for chemical synthesis; laboratory equipment, namely, mobile laboratory equipped with scientific or laboratory apparatus for purification and analysis of synthesized compounds; laboratory equipment, namely, mobile device for the synthesis of macromolecules; Scientific and laboratory apparatus for chemical or biological analysis and/or synthesis; laboratory equipment, namely, mobile production station of biological macromolecules for laboratory or and for cell culturing for therapeutic use; Bioreactors for laboratory or and for cell culturing for therapeutic use
- GS0071: Bioreactors for use in manufacturing biopharmaceuticals; Filling machines, in particular for use for filling biopharmaceutical compositions into containers; Industry roboters being industrial robots
- GS0051: Chemical preparations for medical use, in particular biological macromolecules, for therapeutic and preventive treatment of tumor diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; Pharmaceutical preparations namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of cancers, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; Pharmaceuticals preparations and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment or prevention of infectious diseases, allergies, autoimmune disorders and tumour diseases, for the treatment of metabolic disorders and for the treatment of inherited genetic diseases or for protein or enzyme replacement therapy; Gene therapeutic preparations being Nucleic acid macromolecules for in vivo or in vitro expression for human and veterinary use; Dietetic substances adapted for medical use, in particular substances for food supplements; Vaccines
- PM0001: SHARE VAC
- GS0011: Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes
- GS0441: Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for the treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for the treatment of metabolic disorders; Vaccination services in the nature of administering vaccines to patients
- GS0421: Scientific and technological services, namely, and scientific research , in particular for identification, testing and characterisation of biological molecules; scientific research in the nature of pre-clinical and clinical testing of macromolecules for others; Custom synthesis of chemical compounds, in particular biological macromolecules
Case File Event Statements
-
8/14/2024 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
1/17/2025 - 10 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
2/20/2025 - 8 months ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/4/2025 - 8 months ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/4/2025 - 8 months ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/3/2025 - 5 months ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/3/2025 - 5 months ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
3/4/2025 - 8 months ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
6/3/2025 - 5 months ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
7/14/2025 - 4 months ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA